Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SciSparc Ltd. ( (SPRC) ) has issued an update.
On November 18, 2025, SciSparc Ltd. released its unaudited consolidated interim financial statements for the first half of 2025. The report provides insights into the company’s financial position as of June 30, 2025, including details on assets, liabilities, and equity. This financial disclosure is crucial for stakeholders to assess the company’s financial health and operational performance during the period, which may influence future investment decisions.
More about SciSparc Ltd.
SciSparc Ltd. is a company based in Tel Aviv, Israel, operating in the biotechnology industry. The company focuses on developing therapies for the treatment of disorders related to the central nervous system, leveraging cannabinoid pharmaceuticals.
Average Trading Volume: 4,714,491
Technical Sentiment Signal: Sell
Current Market Cap: $3.89M
For a thorough assessment of SPRC stock, go to TipRanks’ Stock Analysis page.